Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World Study
Sing Yue Sim,1 Arevik Ghulakhszian,2 Amal Minocha,1 Dhannie Ramcharan,2 Soroush Nokhostin,3 Richard Cheong-Leen,1 Sheena George,1 Esther Posner,3 Christiana Dinah2 1Department of Ophthalmology, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK; 2Department of Ophthalmology, London North We...
Guardado en:
Autores principales: | Sim SY, Ghulakhszian A, Minocha A, Ramcharan D, Nokhostin S, Cheong-Leen R, George S, Posner E, Dinah C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e053bf9ab6514aaca7783976f516b13a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study
por: Kern C, et al.
Publicado: (2020) -
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
por: Nudleman E, et al.
Publicado: (2016) -
Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
por: Karttunen T, et al.
Publicado: (2019) -
Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
por: Spooner KL, et al.
Publicado: (2019) -
Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
por: Xiu-Xian Wang, et al.
Publicado: (2021)